This procurement opportunity involves the supply of reagents and laboratory consumables based on the request of the contracting authority for microbiology and various laboratory analyzers. The specific items include reagents for the Biolis 30 and Biolis 24i Premium biochemical analyzers, the i-chrom
Contract awarded. Originally published 1 years ago.
Only 2 prior awards here — too little to read.
In healthcare medical, Multiprofile Hospital for Active Treatment - Blagoevgrad AD has awarded 2 contracts to 1 supplier.
Across healthcare medical, the most active winners are URTICA SP Z O O, SALUS INTERNATIONAL SP Z O O, URTICA SP Z OO — the field to beat, or your route in as a partner.
This contract opportunity involves the supply of medical devices and consumables for the operation of Blagoevgrad Multi-Profiling Hospital. Suppliers are invited to provide a range of items including but not limited to: needles, syringes, bandaging materials, gloves, catheters, surgical instruments,
This procurement opportunity involves the supply of reagents and laboratory consumables based on the requests from the Blagoevgrad Hospital. The items include supplies for microbiology, biochemical analyzers (Biolis 30 and Biolis 24i Premium), immunofluorometer (i-chroma), blood gas analyzer (MEDICA
This public procurement contract is for the supply of medical devices and consumables for the operating room, gastroenterology department, and surgical operating consumables for the Blagoevgrad Multi-Profiling Hospital. The contract includes the delivery of specific medical devices and consumables b
NHS Scotland is seeking suppliers of generic and biosimilar cancer medicines to improve patient access and optimize healthcare costs.
Royal Borough of Greenwich is commissioning a School Health and Wellbeing Service to deliver preventative health and early intervention support for children and young people aged 5-19 years across the borough, with contract commencement in April 2027.
Suffolk County Council is testing market interest for postal delivery of nicotine replacement therapy and smoking cessation medications to improve accessibility for local residents.
PSD Scotland is engaging with the market to explore delivery solutions for a national Targeted Lung Cancer Screening Programme for smokers aged 55-74 in Scotland.
